Orthofix Medical (OFIX) Gross Profit (2010 - 2026)

Orthofix Medical (OFIX) has reported Gross Profit for 17 consecutive years, with $149.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Gross Profit rose 7.29% year-over-year to $149.7 million; the trailing twelve-month figure through Jun 2026 stood at $594.1 million (up 9.0% YoY), and the FY2025 full-year result was $566.0 million, up 3.69% from the prior year.
• Gross Profit was $149.7 million for Q2 2026 at Orthofix Medical, up from $139.5 million in the prior quarter.
• The five-year high for Gross Profit was $156.3 million in Q4 2025, with the low at $78.1 million in Q1 2022.
• Historically, Gross Profit has averaged $123.6 million across 5 years, with a median of $131.0 million in 2024.
• Annual changes were most pronounced in 2022 — Gross Profit retreated 7.97% — and 2023, when it jumped 53.21%.
• Tracing OFIX's Gross Profit over 5 years: stood at $89.2 million in 2022, then soared by 53.21% to $136.6 million in 2023, then increased by 8.94% to $148.8 million in 2024, then advanced by 5.04% to $156.3 million in 2025, then fell by 4.24% to $149.7 million in 2026.
• Per Business Quant data, the three most recent Gross Profit figures were $149.7 million in Q2 2026, $139.5 million in Q1 2026, and $156.3 million in Q4 2025.